1Maximo V, Sobrinho-Simoes M. Hurthle cell tumors of the thyroid:a review with emphasis on mitochondrial abnormalities with clinical relevance[J3]. Virchows Arch,2000,437(2):107.
2Sreelekha TT,Pradeep VM,Vijayalakshmi K,et al. In situ apoptosis in the thyroid[J]. Thyroid,2000,10(2):117.
3Moore D, Ohene-Fianko D, Garcia B, et al. Apoptosis in thyroid neoplasmas., relationship with p53 and bel-2 expression[J], Histopatholgy, 1998,32(1) : 35.
4Manetto V,Lorenzini R,Cordon-Cardo C, et al. bcl-2 and bax expression in thyroid tumours. An immunohistochemical and western blot analysis[J]. Virchows Arch, 1997,430(2):125.
5Basolo F,Fiore L,Fusco A,et al. Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bel-2 gene[J]. Int J Cancer,1999,81(6) :956.
6Fiore L, Basolo F, Baldanzi A, et al. Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyoid carcinoma[J]. Lab Invest,2000,80(9) :1413.
7Hinze R,Gimm O, Taubert H, et al. Regulation of proliferation and apoptosis in sporadic and hereditary medullary thyroid carcinomas and their putative precursor lesions [J]. Virchows Arch,2000,437(3):256.
8Soda G,Antonaci A,Bosco D,et al. Expression of bcl-2,cerbB-2, p5 3, and p21 ( waf1-cip1 ) protein in thyoid carcinomas[J]. J Exp Clin Cancer Res, 1999,18(3):363.
10Pestereli HE,Ogus M,Oren N,et al. bcl-2 and p53 expression in insular and in well-differentiated thyroid carcinomas with an insular pattern [J]. Endocr Pathol, 2001,12(3):301.
